Effect of Physical Activity and/or Probiotics on Body Composition and Physiological Parameters in Women

NCT ID: NCT06746220

Last Updated: 2025-12-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-16

Study Completion Date

2027-12-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a prospective, comparative, double-blind, randomized, monocentric study.

The objective of this project is to evaluate the effects on health of probiotic supplementation (PS) with or without physical activity (PA). Participants who meet the study criteria will be randomized into 4 groups: probiotic and physical activity group (A+), probiotic and non-physical activity group (A-), placebo and physical activity group (T+), placebo and non-physical activity group (T-).

The probiotics used are Lactibiane® Reference provided by Pileje Laboratory. The study population are healthy women (university students) who do not practice sports. A total of 120 participants will participate.

At inclusion, each participant will undergo a medical examination, collect microbiota and salivary samples and perform different tests (questionnaires, assessments of strength and endurance). Then, a follow up phase will last 6 weeks. Each participant will receive a pillbox containing capsules (probiotic or placebo in a double-blind manner). Participants which randomized in the PA groups (A+ and A-) will perform 2 physical activity sessions per week for 6 weeks. At the end of this follow up phase, tests conducting during inclusion will be performed again.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Rationale: Nowadays, the intestinal microbiota is recognized as a significant factor in the health of the host organism. It has an impact on the immune system, the hypothalamo-hypophyseal adrenal axis, the overall state of the individual such as body composition and muscle activity. The intestinal microbiota has also an impact on digestion and associated problems. However, its balance is fragile and can be easily disrupted by a diet rich in proteins or carbohydrates, medications, contraceptive use or lack of physical activity (PA).To restore this balance, subjects may modify their diet, take probiotic supplements (PS) or engage in physical activity. Currently, studies remain limited, particularly regarding effects of physical activity and/or probiotic have never been explored especially in women. The objective of this project is therefore to explore effects of PS and/or PA on the mental and physical health of the holobiont.

Method: Each participant will, during an initial visit, undergo a medical examination (ECG, anthropometric measurements) to ensure there are no contraindications to engaging in physical activity or taking probiotics. Then, we will conduct the first collections of intestinal microbiota and salivary cortisol, initial evaluations of anxiety, depression, and self-esteem (indicators of mental health with questionnaires), as well as assessments of strength and endurance (indicators of physical health), body composition, and nutritional parameters. Following this, participants will be assigned to experimental groups, and we will distribute pillboxes containing capsules (probiotic or placebo in a double-blind manner). Participants in the PA groups (A+ and A-) will perform two 45-minute physical activity sessions per week for 6 weeks, consisting of muscle strengthening and endurance exercises. Participants in the sedentary groups (T+ and T-) will be contacted by phone once a week to ensure proper protocol adherence. At the end of the 6 weeks, we will repeat the tests conducted during the initial visit.

Probiotics: The probiotics used are Lactibiane® Reference, composed of 4 probiotic strains (Bifidobacterium longum LA101, Lactobacillus helveticus LA102, Lactobacillus lactis LA103, Streptococcus thermophilus LA104) dosed at 10 billion per capsule provided by Pileje laboratory. Placebos are also provided by Pileje laboratory.

Statistics: Having no proven hypothesis on the effect of physical activity and/or probiotic supplementation on the population, we started with inclusion of 120 participants in total. This will allow to highlight a moderate effect size (0.25) for the primary endpoint, under the hypothesis of an alpha risk of 0.05, with a power of 80%. and representing 20% lost to follow-up.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Women

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Microbiota Probiotics Physical activity Health women

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

This is a prospective, comparative, double-blind, randomized, monocentric study to explore effects of PA and/or PS on healthy women.
Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Participants Investigators
Open label for physical activity or no-physical activity (A versus T groups). Double-blind for placebo/probiotic supplementation (+ versus - groups)

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A+ group (probiotic and physical activity)

Microbiota sample Salivary sample Quality of life questionnaires Nutritional evaluation Assessment of physical health Physical activity Treatment with placebo or probiotic

Group Type EXPERIMENTAL

Microbiota sample

Intervention Type OTHER

Microbiota sample: one sample at inclusion and one sample at the end of the study

Salivary sample

Intervention Type OTHER

Salivary sample: one sample at inclusion and one sample at the end of the study. In the morning, on an empty stomach.

Quality of life questionnaires

Intervention Type OTHER

Quality of life questionnaires: 5 auto-questionnaires to be filled at inclusion and at the end of the study

Nutritional evaluation

Intervention Type OTHER

Nutritional evaluation: food diary completed by participants for 3 consecutive days at inclusion and at the end of the study

Assessment of physical health

Intervention Type OTHER

Assessment of physical health : 3 tests to assess strength and endurance. These tests will be performed at inclusion and at the end of the study.

Physical activity

Intervention Type OTHER

Physical activity: 2 sessions per week for 6 weeks. For each session, 45 minutes of physical activity consisting of muscle strengthening and endurance exercises.

Treatment with placebo or probiotic

Intervention Type OTHER

Treatment with placebo or probiotic: 1 capsule per day during 42 consecutive days. In the morning, on an empty stomach with a large glass of water 20 minutes before the meal

A- group (probiotic and non-physical activity)

Microbiota sample Salivary sample Quality of life questionnaires Nutritional evaluation Assessment of physical health Physical activity Treatment with placebo or probiotic

Group Type EXPERIMENTAL

Microbiota sample

Intervention Type OTHER

Microbiota sample: one sample at inclusion and one sample at the end of the study

Salivary sample

Intervention Type OTHER

Salivary sample: one sample at inclusion and one sample at the end of the study. In the morning, on an empty stomach.

Quality of life questionnaires

Intervention Type OTHER

Quality of life questionnaires: 5 auto-questionnaires to be filled at inclusion and at the end of the study

Nutritional evaluation

Intervention Type OTHER

Nutritional evaluation: food diary completed by participants for 3 consecutive days at inclusion and at the end of the study

Assessment of physical health

Intervention Type OTHER

Assessment of physical health : 3 tests to assess strength and endurance. These tests will be performed at inclusion and at the end of the study.

Physical activity

Intervention Type OTHER

Physical activity: 2 sessions per week for 6 weeks. For each session, 45 minutes of physical activity consisting of muscle strengthening and endurance exercises.

Treatment with placebo or probiotic

Intervention Type OTHER

Treatment with placebo or probiotic: 1 capsule per day during 42 consecutive days. In the morning, on an empty stomach with a large glass of water 20 minutes before the meal

T+ group (placebo and physical activity)

Microbiota sample Salivary sample Quality of life questionnaires Nutritional evaluation Assessment of physical health Physical activity Treatment with placebo or probiotic

Group Type EXPERIMENTAL

Microbiota sample

Intervention Type OTHER

Microbiota sample: one sample at inclusion and one sample at the end of the study

Salivary sample

Intervention Type OTHER

Salivary sample: one sample at inclusion and one sample at the end of the study. In the morning, on an empty stomach.

Quality of life questionnaires

Intervention Type OTHER

Quality of life questionnaires: 5 auto-questionnaires to be filled at inclusion and at the end of the study

Nutritional evaluation

Intervention Type OTHER

Nutritional evaluation: food diary completed by participants for 3 consecutive days at inclusion and at the end of the study

Assessment of physical health

Intervention Type OTHER

Assessment of physical health : 3 tests to assess strength and endurance. These tests will be performed at inclusion and at the end of the study.

Treatment with placebo or probiotic

Intervention Type OTHER

Treatment with placebo or probiotic: 1 capsule per day during 42 consecutive days. In the morning, on an empty stomach with a large glass of water 20 minutes before the meal

T- group (placebo and non-physical activity)

Microbiota sample Salivary sample Quality of life questionnaires Nutritional evaluation Assessment of physical health Physical activity Treatment with placebo or probiotic

Group Type EXPERIMENTAL

Microbiota sample

Intervention Type OTHER

Microbiota sample: one sample at inclusion and one sample at the end of the study

Salivary sample

Intervention Type OTHER

Salivary sample: one sample at inclusion and one sample at the end of the study. In the morning, on an empty stomach.

Quality of life questionnaires

Intervention Type OTHER

Quality of life questionnaires: 5 auto-questionnaires to be filled at inclusion and at the end of the study

Nutritional evaluation

Intervention Type OTHER

Nutritional evaluation: food diary completed by participants for 3 consecutive days at inclusion and at the end of the study

Assessment of physical health

Intervention Type OTHER

Assessment of physical health : 3 tests to assess strength and endurance. These tests will be performed at inclusion and at the end of the study.

Treatment with placebo or probiotic

Intervention Type OTHER

Treatment with placebo or probiotic: 1 capsule per day during 42 consecutive days. In the morning, on an empty stomach with a large glass of water 20 minutes before the meal

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Microbiota sample

Microbiota sample: one sample at inclusion and one sample at the end of the study

Intervention Type OTHER

Salivary sample

Salivary sample: one sample at inclusion and one sample at the end of the study. In the morning, on an empty stomach.

Intervention Type OTHER

Quality of life questionnaires

Quality of life questionnaires: 5 auto-questionnaires to be filled at inclusion and at the end of the study

Intervention Type OTHER

Nutritional evaluation

Nutritional evaluation: food diary completed by participants for 3 consecutive days at inclusion and at the end of the study

Intervention Type OTHER

Assessment of physical health

Assessment of physical health : 3 tests to assess strength and endurance. These tests will be performed at inclusion and at the end of the study.

Intervention Type OTHER

Physical activity

Physical activity: 2 sessions per week for 6 weeks. For each session, 45 minutes of physical activity consisting of muscle strengthening and endurance exercises.

Intervention Type OTHER

Treatment with placebo or probiotic

Treatment with placebo or probiotic: 1 capsule per day during 42 consecutive days. In the morning, on an empty stomach with a large glass of water 20 minutes before the meal

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Being female
2. Age ≥ 18 years old
3. Have a BMI between 18.5 and 30 kg/m2
4. Be registered as a student at the University of Orléans
5. Be non-athletic
6. Have no contraindication to the practice of physical activity
7. All participants must sign informed consent before the start of the study

Exclusion Criteria

1. Smokers \>10 cigarettes per day
2. Having treatment for a pathology at the time of inclusion
3. Taking a probiotic supplement during the last month prior to inclusion
4. Practice physical activity regularly (150 minutes/week of moderate physical activity according to the WHO)
5. Participant under guardianship or curators
6. Pregnant or breastfeeding women
7. Menopausal women
8. Allergy to any excipient known to be present in the probiotic or placebo formulation
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Régional d'Orléans

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Virgile AMIOT, Doctor

Role: PRINCIPAL_INVESTIGATOR

CHU Orléans

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Center Hospitalier Universitaire d'Orléans

Orléans, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Virgile AMIOT, Doctor

Role: CONTACT

Phone: 0238514785

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Virgile AMIOT, Doctor

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Aya V, Florez A, Perez L, Ramirez JD. Association between physical activity and changes in intestinal microbiota composition: A systematic review. PLoS One. 2021 Feb 25;16(2):e0247039. doi: 10.1371/journal.pone.0247039. eCollection 2021.

Reference Type BACKGROUND
PMID: 33630874 (View on PubMed)

Aya V, Jimenez P, Munoz E, Ramirez JD. Effects of exercise and physical activity on gut microbiota composition and function in older adults: a systematic review. BMC Geriatr. 2023 Jun 12;23(1):364. doi: 10.1186/s12877-023-04066-y.

Reference Type BACKGROUND
PMID: 37308839 (View on PubMed)

Angelakis E, Armougom F, Million M, Raoult D. The relationship between gut microbiota and weight gain in humans. Future Microbiol. 2012 Jan;7(1):91-109. doi: 10.2217/fmb.11.142.

Reference Type BACKGROUND
PMID: 22191449 (View on PubMed)

Bastianelli C, Farris M, Bianchi P, Benagiano G. The effect of different contraceptive methods on the vaginal microbiome. Expert Rev Clin Pharmacol. 2021 Jul;14(7):821-836. doi: 10.1080/17512433.2021.1917373. Epub 2021 Apr 23.

Reference Type BACKGROUND
PMID: 33863265 (View on PubMed)

Boisseau N, Barnich N, Koechlin-Ramonatxo C. The Nutrition-Microbiota-Physical Activity Triad: An Inspiring New Concept for Health and Sports Performance. Nutrients. 2022 Feb 22;14(5):924. doi: 10.3390/nu14050924.

Reference Type BACKGROUND
PMID: 35267899 (View on PubMed)

Alvarez-Arrano V, Martin-Pelaez S. Effects of Probiotics and Synbiotics on Weight Loss in Subjects with Overweight or Obesity: A Systematic Review. Nutrients. 2021 Oct 17;13(10):3627. doi: 10.3390/nu13103627.

Reference Type BACKGROUND
PMID: 34684633 (View on PubMed)

Abenavoli L, Scarpellini E, Colica C, Boccuto L, Salehi B, Sharifi-Rad J, Aiello V, Romano B, De Lorenzo A, Izzo AA, Capasso R. Gut Microbiota and Obesity: A Role for Probiotics. Nutrients. 2019 Nov 7;11(11):2690. doi: 10.3390/nu11112690.

Reference Type BACKGROUND
PMID: 31703257 (View on PubMed)

Allen JM, Mailing LJ, Niemiro GM, Moore R, Cook MD, White BA, Holscher HD, Woods JA. Exercise Alters Gut Microbiota Composition and Function in Lean and Obese Humans. Med Sci Sports Exerc. 2018 Apr;50(4):747-757. doi: 10.1249/MSS.0000000000001495.

Reference Type BACKGROUND
PMID: 29166320 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CHUO-2024-01

Identifier Type: -

Identifier Source: org_study_id